Centerline Biomedical Announces Philip D. Rackliffe, MBA as Chief Executive Officer (CEO) Effective October 21st, 2019

Centerline Biomedical Wins SBIR Phase II Award from NIH

Centerline Biomedical Wins SBIR Phase II Award from NIH National Heart, Lung, and Blood Institute Awards $1.5M to advance IOPS technology CLEVELAND, OH – Centerline Biomedical, Inc., announced that it has been awarded its third small business grant from the NIH...
Centerline Biomedical Announces Philip D. Rackliffe, MBA as Chief Executive Officer (CEO) Effective October 21st, 2019

Bringing about the promise of minimally invasive surgery

“Keyhole” surgery – a catch-all term used to describe a variety of minimally-invasive surgical therapies – has become a field of rapid innovation and the treatment of choice when it is available. On the supply side, growth is fueled by advances in surgical technique...